LPL Financial
BBIO icon

LPL Financial’s BridgeBio Pharma BBIO Stock Holding History

LPL Financial’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67M Buy
22,439
+875
+4% +$61.3K ﹤0.01% 3951
2026
Q1 		$1.6M Buy
21,564
+8,214
+62% +$595K ﹤0.01% 3712
2025
Q4 		$1.02M Buy
13,350
+1,847
+16% +$121K ﹤0.01% 4052
2025
Q3 		$597K Buy
11,503
+6,456
+128% +$315K ﹤0.01% 4480
2025
Q2 		$218K Buy
+5,047
New +$184K ﹤0.01% 5026
2022
Q3 		– Sell
-10,832
Closed -$98K – 4423
2022
Q2 		$98K Sell
10,832
-5,466
-34% -$45.7K ﹤0.01% 4134
2022
Q1 		$165K Buy
+16,298
New +$167K ﹤0.01% 3876

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

LPL Financial's BBIO Position: Q2 2026 in Review

LPL Financial increased its BridgeBio Pharma (BBIO) stake by 4.1% in Q2 2026, buying an estimated $61.3K and bringing the position to 22,439 shares worth $1.67M. The position accounts for ﹤0.01% of the portfolio, ranked #3951.

LPL Financial first reported a position in BBIO in Q1 2022 and has held it in 7 quarters since. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • LPL Financial held 22,439 shares of BridgeBio Pharma worth $1.67M as of Q2 2026.
  • LPL Financial bought 875 BridgeBio Pharma shares in Q2 2026, an estimated $61.3K.
  • BridgeBio Pharma made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #3951 holding.
  • LPL Financial first reported a position in BridgeBio Pharma in Q1 2022 and has held it in 7 quarters since.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.